Concepedia

Carina Hage

CH

11

Publications

692

Citations

11

H-Index

2013

Active since

Affiliations

Roche (Switzerland)(Current)

Roche Pharma AG (Germany)

RWTH Aachen University

University of Basel

Center for Integrated Protein Science Munich

Carina Hage is an author at Roche (Switzerland) specializing in cell biology, medicine, and radiation oncology.

ORCID

Top concepts

Publications per year

2013–2024

11

Publications

11

Sorafenib Induces Pyroptosis in Macrophages and Triggers Natural Killer Cell–Mediated Cytotoxicity Against Hepatocellular Carcinoma

Carina Hage, Sabine Hoves, Léanne Strauss et al. · Hepatology · 2019 · 229 citations

The novel c-Met inhibitor cabozantinib overcomes gemcitabine resistance and stem cell signaling in pancreatic cancer

Carina Hage, Vanessa Rausch, Nathalia A. Giese et al. · Cell Death and Disease · 2013 · 114 citations · Full text

, , +13

Protease-activation using anti-idiotypic masks enables tumor specificity of a folate receptor 1-T cell bispecific antibody

Martina Geiger, Kay‐Gunnar Stubenrauch, Johannes Sam et al. · Nature Communications · 2020 · 88 citations · Full text

Human immunocompetent Organ-on-Chip platforms allow safety profiling of tumor-targeted T-cell bispecific antibodies

S. Jordan Kerns, Chaitra Belgur, Debora B. Petropolis et al. · eLife · 2021 · 69 citations · Full text

, , +17

Macrophage depletion induces edema through release of matrix-degrading proteases and proteoglycan deposition

Stefan Bissinger, Carina Hage, Vinona Wagner et al. · Science Translational Medicine · 2021 · 50 citations · Full text

Rows per page

1–5 of 11